Intel Corp (INTC) — Fundamental Analysis
Snapshot & Big Picture
Intel is one of the world's largest semiconductor companies, historically dominant in PC and server CPUs. Over the past several years, the company has faced intensifying competitive pressure from AMD, a structural shift toward custom silicon by cloud hyperscalers, and a costly strategic pivot to become a contract chip manufacturer (foundry). The data below tells the story of a business that was highly profitable as recently as 2020–2021, but has since undergone a painful reset — with revenues shrinking, margins collapsing, and capital expenditures at historically elevated levels. The most recent quarterly data (Q2 2026) shows some tentative signs of stabilization, though the recovery remains fragile.
Latest Quarter Snapshot (Q2 FY2026, period ended June 27, 2026)
This is the most current data available, more recent than the annual figures, and provides the clearest read on where Intel stands today.
| Metric | Value |
|---|---|
| Revenue | $16.1B |
| EBITDA | $1.85B |
| Gross Margin | 40.4% |
| Operating Margin | 11.1% |
| Net Margin | -68.4% |
| Current Ratio | 1.60 |
| Debt-to-Equity | 0.58 |
| Capital Expenditures | $3.6B |
| CapEx-to-Revenue | 22.5% |
The headline gross margin of 40.4% is actually encouraging — it is at its highest level since the FY2022 period and suggests some recovery in product mix and manufacturing efficiency. The operating margin of 11.1% is a meaningful rebound from the deep losses of FY2024. However, the net margin of -68.4% reflects large below-the-line charges — likely impairment, restructuring, or other non-cash items — that are masking the operating-level improvement. Investors should look past the net loss headline and focus on whether the gross and operating margin recovery is durable. CapEx-to-revenue of 22.5% is notably lower than the peak years (FY2023–FY2024), indicating Intel is beginning to modulate its foundry investment spending.
Profitability — Multi-Year Trend
| Fiscal Year End | Revenue | Gross Margin | Operating Margin | Net Margin | EBITDA |
|---|---|---|---|---|---|
| 2016-12-31 | $59.4B | 61.0% | 22.1% | 17.4% | $13.4B |
| 2017-12-30 | $62.8B | 62.3% | 28.8% | 15.3% | $18.2B |
| 2018-12-29 | $70.8B | 61.7% | 32.9% | 29.7% | $23.5B |
| 2019-12-28 | $72.0B | 58.6% | 30.6% | 29.2% | $22.2B |
| 2020-12-26 | $77.9B | 56.0% | 30.4% | 26.8% | $35.9B |
| 2021-12-25 | $79.0B | 55.4% | 24.6% | 25.1% | $31.2B |
| 2022-12-31 | $63.1B | 42.6% | 3.7% | 12.7% | $15.4B |
| 2023-12-30 | $54.2B | 40.0% | 0.2% | 3.1% | $9.7B |
| 2024-12-28 | $53.1B | 32.7% | -22.0% | -35.3% | -$299M |
| 2025-12-27 | $52.9B | 34.8% | -4.2% | -0.5% | $9.5B |
The profitability decline from Intel's peak years is stark. Gross margins fell from the high-50s/low-60s range (2016–2021) to a trough of 32.7% in FY2024 — a near-halving of gross profitability. FY2024 was the low point, with a deeply negative EBITDA of -$299M and an operating margin of -22%. FY2025 shows a material improvement: gross margins recovered to 34.8%, operating margin improved to -4.2%, and EBITDA rebounded to $9.5B. Combined with the Q2 FY2026 data showing further gross margin expansion to 40.4% and positive operating margin of 11.1%, there is a credible — though still early-stage — recovery narrative forming.
Financial Health & Capital Expenditures
| Fiscal Year End | Current Ratio | Debt-to-Equity | Capital Expenditures | CapEx-to-Revenue |
|---|---|---|---|---|
| 2016-12-31 | 1.75 | 0.38 | $9.6B | 16.2% |
| 2017-12-30 | 1.69 | 0.38 | $11.8B | 18.8% |
| 2018-12-29 | 1.73 | 0.35 | $15.2B | 21.4% |
| 2019-12-28 | 1.40 | 0.37 | $16.2B | 22.5% |
| 2020-12-26 | 1.91 | 0.45 | $14.3B | 18.3% |
| 2021-12-25 | 2.13 | 0.40 | $18.7B | 23.7% |
| 2022-12-31 | 1.57 | 0.38 | $24.8B | 39.4% |
| 2023-12-30 | 1.54 | 0.47 | $25.8B | 47.5% |
| 2024-12-28 | 1.33 | 0.50 | $23.9B | 45.1% |
| 2025-12-27 | 2.02 | 0.41 | $14.6B | 27.7% |
| Q2 FY2026 (TTM proxy) | 1.60 | 0.58 | $3.6B (qtrly) | 22.5% (qtrly) |
Liquidity: The current ratio improved dramatically in FY2025 to 2.02 from the dangerously low 1.33 in FY2024, suggesting Intel shored up its near-term liquidity. The Q2 FY2026 current ratio of 1.60 remains healthy. Debt-to-equity has stayed in the 0.35–0.58 range throughout the decade — Intel is not over-leveraged in absolute terms, though it has crept up recently.
Capital Expenditures: This is the defining financial story of Intel's transformation era. CapEx surged from a historically normal 16–24% of revenue to a peak of 47.5% of revenue in FY2023 ($25.8B) as Intel aggressively built out its foundry infrastructure under its IDM 2.0 strategy. Sustaining that level of spending while revenues were declining created massive free cash flow destruction and was a primary driver of the balance sheet stress seen in FY2024. The sharp pullback to $14.6B (27.7% of revenue) in FY2025, and a quarterly run-rate of $3.6B (22.5% of revenue) in Q2 FY2026, signals that Intel is deliberately dialing back its foundry investment ambitions — likely a pragmatic response to financial constraints and a reassessment of its competitive position. This reduction in capital intensity should improve free cash flow generation materially, but it also raises questions about whether Intel can execute its long-term foundry roadmap with reduced investment.
Growth — Revenue CAGR
| Window | Start Year | End Year | Start Revenue | End Revenue | CAGR |
|---|---|---|---|---|---|
| 3-Year | FY2022 (Dec 31, 2022) | FY2025 (Dec 27, 2025) | $63.1B | $52.9B | -5.7% |
| 5-Year | FY2020 (Dec 26, 2020) | FY2025 (Dec 27, 2025) | $77.9B | $52.9B | -7.5% |
| 10-Year | N/A | N/A | N/A | N/A | Not available — SEC filing history in this dataset does not extend back 10 full fiscal years from the most recent period end. |
Both the 3-year and 5-year revenue CAGRs are negative — -5.7% and -7.5% respectively — reflecting Intel's sustained revenue contraction from its FY2020–2021 peak of ~$77–79B down to roughly $53B. This is not a mild cyclical dip; it represents the loss of market share in key segments and the industry-wide digestion of pandemic-era inventory surges. The 10-year CAGR window is unavailable given the data provided. Revenue stabilization appears to have occurred around the $52–54B range over FY2023–FY2025, and the most recent quarterly data does not yet point to a breakout in top-line growth.
Plain English Summary
Intel was one of the most profitable technology companies in the world as recently as 2020, generating nearly $78B in revenue with gross margins above 55% and net margins approaching 27%. Since then, the company has been through a painful multi-year reckoning: revenues have fallen by roughly a third from peak, gross margins have dropped by nearly 20 percentage points, and FY2024 was a near-catastrophic year with negative EBITDA, a net loss exceeding 35% of revenue, and nearly $24B in capital spending on a business generating barely $53B in sales. The good news is that FY2025 marked the beginning of a measurable recovery — EBITDA bounced back to $9.5B, gross margins improved, and CapEx was brought under control. The most recent quarterly data from Q2 FY2026 is arguably the most encouraging in years, with gross margins back above 40% and a positive operating margin of 11%, though a large net loss driven by below-the-line charges obscures that progress. The core challenges remain: Intel must prove it can grow revenue again in the face of AMD competition and the shift to custom AI chips, it must demonstrate its foundry business can attract external customers, and it must do all of this while right-sizing an investment program that strained its finances for three consecutive years. Intel is not a turnaround story yet — but the trajectory in the most recent data is, cautiously, pointed in the right direction.

Leave a Comment